Is Sanara MedTech Inc. (SMTI) Halal?
Shariah Screening — 5 Standards
Based on financial data from December 2024
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 19.1% / 30% | 9.4% / 30% | 8.0% / 30% | 0.03% / 5% | ✓ HALAL |
| DJIM | 19.1% / 33% | 9.4% / 33% | 8.0% / 33% | 0.03% / 5% | ✓ HALAL |
| MSCI | 36.6% / 33% | 18.0% / 33% | 15.4% / 33% | 0.03% / 5% | ✗ NOT HALAL |
| S&P | 19.1% / 33% | 9.4% / 33% | 8.0% / 33% | 0.03% / 5% | ✓ HALAL |
| FTSE | 36.6% / 33% | 18.0% / 33% | 15.4% / 50% | 0.03% / 5% | ✗ NOT HALAL |
Financial Highlights
Profitability
| Gross Margin | 92.7% | |
| Operating Margin | 10.5% | |
| Net Margin | -36.4% | |
| Return on Equity (ROE) | -1.8% | |
| Return on Assets (ROA) | 7.1% |
Cash Flow & Balance Sheet
| Operating Cash Flow | -$23,784 |
| Free Cash Flow | -$253,084 |
| Total Debt | $32M |
| Debt-to-Equity | 812.7 |
| Current Ratio | 1.8 |
| Total Assets | $88M |
Price & Trading
| Last Close | $18.01 |
| 50-Day MA | $20.09 |
| 200-Day MA | $25.86 |
| Avg Volume | 59K |
| Beta | 1.1 |
|
52-Week Range
$16.05
| |
About Sanara MedTech Inc. (SMTI)
Sanara MedTech Inc., a medical technology company, develops, markets, and distributes surgical solutions to physicians, hospitals, clinics, and post-acute care settings in the United States. The company offers CellerateRX Surgical, a medical hydrolysate of Type I bovine collagen indicated for the management of surgical, traumatic, and partial- and full-thickness wounds, as well as first- and second-degree burns. It also develops BIASURGE, a no-rinse surgical solution used for wound irrigation; FORTIFY Tissue Repair Graft(FORTIFY TRG), a freeze-dried, multi-layer small intestinal submucosa extracellular matrix sheet; BiFORM, an osteoconductive, bioactive, porous implant that allows bony ingrowth across the graft site and it can be used as a strip or molded into a putty to fill a bone defect; ACTIGEN Inductive Bone Matrix, a naturally derived, differentiated allograft matrix with robust handling properties; ALLOCYTE Plus, a human allograft cellular bone matrix containing bone-derived progenitor cells and conformable bone fibers; and TEXAGEN, a multi-layer amniotic membrane allograft used as an anatomical barrier with robust handling that can be sutured for securement. The company has a license agreement with Rochal to develop, market, and sell antimicrobial products that include BIASURGE Advanced Surgical Solution, BIAKOS Antimicrobial Wound Gel, and BIAKOS Antimicrobial Skin and Wound Cleanser for the prevention and treatment of microbes on the human body. Sanara MedTech Inc. was incorporated in 2001 and is based in Fort Worth, Texas.
Purification Calculator
As a halal stock with 0.03% impermissible income, you need to purify your dividends.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is Sanara MedTech Inc. (SMTI) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), Sanara MedTech Inc. is Halal. The company passes all financial ratio thresholds for debt, cash, receivables, and impermissible income. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is Sanara MedTech Inc.'s debt ratio?
Sanara MedTech Inc.'s debt ratio is 19.1% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 36.6%.
Does Sanara MedTech Inc. require dividend purification?
Yes, Sanara MedTech Inc. has an impermissible income ratio of 0.03%, which means 0.03% of any dividends received should be donated to charity as purification. This is because a small portion of the company's revenue comes from non-Shariah-compliant sources.
What are Sanara MedTech Inc.'s key financial metrics?
Sanara MedTech Inc. has a market capitalization of $155M, and revenue of $87M. The company maintains a gross margin of 92.7% and a net margin of -36.4%. Return on equity stands at -1.8%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.